Skip to main content

Impaired Renal Function

  • Living reference work entry
  • First Online:
Drug Discovery and Evaluation: Pharmacological Assays
  • 525 Accesses

Abstract

Chronic renal failure is a frequent pathological condition in man. An animal model as described by Acott et al. (1987) is of value to test new diuretics under these conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References and Further Reading

Chronic Renal Failure in the Rat

  • Acott PD, Ogborn MR, Crocker JFS (1987) Chronic renal failure in the rat.A surgical model for long-term-toxicological studies. J Pharmacol Methods 18:81–88

    Article  CAS  PubMed  Google Scholar 

  • Freeman RM (1971) The role of magnesium in the pathogenesis of azotemic hypothermia. Proc Soc Exp Biol Med 137:1069–1072

    Article  CAS  PubMed  Google Scholar 

  • Hartenbower DL, Coburn JW (1972) A model of renal insufficiency in the chick. Lab Anim Sci 22:258–261

    CAS  PubMed  Google Scholar 

  • Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S (1995) Angiotensin II receptor antagonist ameliorates renal tubulo-interstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285–1294

    Article  CAS  PubMed  Google Scholar 

  • Klahr S, Morrissey JJ (1997) Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int 52(Suppl 63):111–114

    Google Scholar 

  • Sancho JJ, Qy D, Oms L, Sitges-Serra A, Hammond ME, Arnaud CD, Clark OH (1989) A new experimental model for secondary hyperparathyroidism. Surgery 106:1002–1008

    CAS  PubMed  Google Scholar 

  • Williams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R (1997) Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Methods 37:1–7

    Article  CAS  PubMed  Google Scholar 

Chronic Renal Failure After Subtotal (Five-Sixths) Nephrectomy in Rats

  • Ali SM, Laping NJ, Fredrickson TA, Contino LC, Olson BA, Anderson K, Brooks DP (1998) Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF β1 mRNA expression in rats with chronic renal disease. Pharmacology 57:20–27

    Article  CAS  PubMed  Google Scholar 

  • Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwartz D, Cabiki S, Silverberg D, Iaina A (1995) Oral administration of l-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 47:1515–1521

    Article  CAS  PubMed  Google Scholar 

  • Bardoux P, Martin H, Ahoulay M, Schmitt F, Bouby N, Trinh Trang Tan M, Bankir E (1999) Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc Natl Acad Sci U S A 96:10397–10402

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Barreto-Chaves MLM, Mello-Aires M (1996) Effect of luminal angiotensin II and ANP on early and late cortical distal tubule HCO3-reabsorption.Am J Physiol 271; Ren Fluid Electrolyte Physiol 40:F977–F984

    Google Scholar 

  • Bonilla-Felix M, Hamm LL, Herndon J, Vehaskari VM (1992) Response of cortical collecting ducts from remnant kidneys to arginine vasopressin. Kidney Int 41:1150–1154

    Article  CAS  PubMed  Google Scholar 

  • Brochu E, Lacasse MS, Moreau C, Lebel M, Kingma I, Grose JH, Laviviere R (1999) Endothelin in ETA receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Nephrol Dial Transplant 14:1881–1888

    Article  CAS  PubMed  Google Scholar 

  • Brooks DP, Contino LC, Short BG, Gowan C, Trizna W, Edwards RM (1995) SB 203220: a novel angiotensin II receptor antagonist and renoprotective agent. J Pharmacol Exp Ther 274:1222–1227

    CAS  PubMed  Google Scholar 

  • Brown JH, Lappin TRJ, Elder EG, Bridges MJ, McGeown MG (1990) The metabolism of erythropoietin in the normal and uremic rabbit. Nephrol Dial Transplant 5:855–859

    Article  CAS  PubMed  Google Scholar 

  • Christensen S, Marcussen N, Petersen S, Shalmi M (1992) Effects of uninephrectomy and high protein feeding on lithium-induced chronic renal failure in rats. Ren Physiol Biochem 15:141–149

    CAS  PubMed  Google Scholar 

  • Christensen S, Shalmi M, Hansen AK, Marcussen N (1997) Effects of pepindopril and hydrochlorothiazide on the long-term progression of lithium-induced chronic renal failure in rats. Pharmacol Toxicol 80:132–141

    Article  CAS  PubMed  Google Scholar 

  • Cohen DS, Mathis JE, Dotson RA, Graybill SR, Wosu NJ (1998) Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure. J Cardiovasc Pharmacol 32:87–95

    Article  CAS  PubMed  Google Scholar 

  • Cowley BD Jr, Grantham JJ, Muessel MJ, Kraybill AL, Gattone VH II (1996) Modification of disease progression in rats with inherited polycystic kidney disease. Am J Kidney Dis 27:865–879

    Article  PubMed  Google Scholar 

  • Fernadez R, Lopes MJ, De Lira RF, Dantas WFG, Cragoe EJ Jr, Malnic G (1994) Mechanism of acidification along cortical distal tubule of the rat.Am J Physiol 266, Ren Fluid Electrolyte Physiol 35:F218–F226

    Google Scholar 

  • Fine A, Jones D, Kaushal G, LeFal Y, Sharma G (1990) Remnant model of renal failure in the dog: avoidance of second surgery by chemical nephrectomy. Clin Invest Med 13:152–154

    CAS  PubMed  Google Scholar 

  • Garcia de Boto MJ, Cobo A, Rodriguez J, Fernandez P, Rey C, Santos F (1996) Chronic renal failure and human growth hormone treatment do not modify endothelium-dependent reactions in the rat aorta in vitro. J Auton Pharmacol 16:97–103

    Article  CAS  PubMed  Google Scholar 

  • Fukagawa M, Kaname SY, Igarashi T, Ogata E, Kurokawa K (1991) Regulation of parathyroid hormone synthesis in chronic renal failure in rat. Kidney Int 39:874–881

    Article  CAS  PubMed  Google Scholar 

  • Hamilton DL, Cotes PM (1994) The effect of the submandibular salivary gland on the erythropoietin response to hypoxia in mice with chronic renal failure. Exp Hematol 22:256–260

    CAS  PubMed  Google Scholar 

  • Hazel SJ, Gillespie CM, Moore RJ, Clark RG, Jureidini KF, Martin AA (1994) Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 46:58–68

    Article  CAS  PubMed  Google Scholar 

  • Jarusiripipat C, Chan L, Shapiro JI, Schrier RW (1992) Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats. J Pharmacol Exp Ther 260:243–247

    CAS  PubMed  Google Scholar 

  • Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A (1992) Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42:46–55

    Article  CAS  PubMed  Google Scholar 

  • Kimura M, Suzuki T, Hishida A (1999) A rat model of progressive renal failure produced by microembolism. Am J Pathol 155:1371–1380

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kohzuki M, Yasujima M, Yoshida K, Kanazawa M, Abe K (1994) Antihypertensive and antiproteinuric effects of losartan in spontaneously hypertensive rats with chronic renal failure. Hypertens Res Clin Exp 17:173–178

    Article  CAS  Google Scholar 

  • Kohzuki M, Kanazawa M, Liu PF, Kamimoto M, Yoshida K, Saito T, Yasujima M, Sato T, Abe K (1995) Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors. J Hypertens 13:1785–1790

    CAS  PubMed  Google Scholar 

  • Koumegawa JI, Nagano N, Arai H, Wada N, Kusaka M, Takahashi A (1991) Anemia in new congenital adult type polycystic kidney mice. J Urol 146:1645–1649

    CAS  PubMed  Google Scholar 

  • Lariviere R, Lebel M, Kingma T, Grose JH, Boucher D (1998) Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass. Am J Hypertens 11:989–997

    Article  CAS  PubMed  Google Scholar 

  • Levine DZ, Iacovitti M, Buckman S, Burns KD (1996) Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo. J Clin Invest 97:120–125

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Levine DZ, Iacovitti M, Buckman S, Hinke MT, Luck B, Fryer JN (1997) ANG II-dependent HCO3 − reabsorption in surviving rat renal tubules: expression/activation of H+-ATPase.Am J Physiol 272; Ren Physiol 41:F799–F808

    Google Scholar 

  • Liu DT, Turner SW, Wen C, Witworth JA (1996) Angiotensin converting enzyme inhibition and protein restriction in progression of experimental chronic renal failure. Pathology 28:156–160

    Article  CAS  PubMed  Google Scholar 

  • Luk JKH, Wong EFC, Wong NLM (1995) Downregulation of atrial natriuretic factor clearance receptors in experimental chronic failure in rats.Am J Physiol 269; Heart Circ Physiol 38:H902–G908

    Google Scholar 

  • MacLaughlin M, Monserrat AJ, Muller A, Matoso M, Amorena C (1998) Role of kinins in the renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure. Kidney Blood Press Res 21:329–334

    Article  CAS  PubMed  Google Scholar 

  • Mak RHK, Pak YK (1996) End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure. Kidney Int 50:400–406

    Article  CAS  PubMed  Google Scholar 

  • Nabokov A, Amann K, Wagner J, Gehlen F, Munter K, Ritz E (1996) Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation. Nephrol Dial Transplant 11:514–520

    Article  CAS  PubMed  Google Scholar 

  • Noda M, Fukuda R, Matsuo T, Ohta M, Nagano H, Imura Y, Nishikawa K, Shibouta Y (1997) Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Kidney Int Suppl 51(63):S136–S139

    Google Scholar 

  • Nyengaard JR, Bendtsen TF, Christensen S, Ottosen PD (1994) The number and size of glomeruli in long-term lithium-induced nephropathy in rats. APMIS 102:59–66

    Article  CAS  PubMed  Google Scholar 

  • Pelayo JC, Quan AH, Shanley PF (1990) Angiotensin II control of the renal microcirculation in rats with reduced renal mass.Am J Physiol 258; Ren Fluid Electrolyte Physiol 27:F414–F422

    Google Scholar 

  • Potter GS, Johnson RJ, Fink GD (1997) Role of endothelin in hypertension of experimental chronic renal failure. Hypertension 30:1578–1584

    Article  CAS  PubMed  Google Scholar 

  • Poux JM, Lartigue M, Chaisemartin RA, Galen FX, Leroux-Robert C (1995) Uraemia is necessary for erythropoietin-induced hypertension in rats. Clin Exp Pharmacol Physiol 22:769–771

    Article  CAS  PubMed  Google Scholar 

  • Roczniak A, Fryer JN, Levine DZ, Burns KD (1999) Downregulation of neuronal nitric oxide synthase in the rat remnant kidney. J Am Soc Nephrol 10:704–713

    CAS  PubMed  Google Scholar 

  • Santos F, Chan JCM, Hanna JD, Niimi K, Krieg RJ Jr, Wellons MD (1992) The effect of growth hormone on the growth failure of chronic renal failure. Pediatr Nephrol 6:262–266

    Article  CAS  PubMed  Google Scholar 

  • Schaefer L, Malchow M, Schaefer RM, Ling H, Heidland A, Massry SG (1996) Effects of parathyroid hormone on renal tubular proteinases. Miner Electrolyte Metab 22:182–186

    CAS  PubMed  Google Scholar 

  • Shimizu T, Hata S, Kuroda T, Mihara SI, Fujimoto M (1999) Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats. Eur J Pharmacol 381:39–49

    Article  CAS  PubMed  Google Scholar 

  • Stockelman MG, Lorenz JN, Smith FN, Boivin GP, Sahota A, Tischfield JA, Stambrook PJ (1998) Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency.Am J Physiol 275; Ren Physiol 44:F154–F163

    Google Scholar 

  • Tolins JP, Raij L (1990) Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Hypertension 10:452–461

    Article  Google Scholar 

  • Tonshoff B, Powell DR, Zhao D, Durham SK, Coleman ME, Domene HM, Blum WF, Baxter RC, Moore LC, Kaskel FJ (1997) Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and −2 gene expression in experimental uremia. Endocrinology 138:938–946

    Article  CAS  PubMed  Google Scholar 

  • Urena P, Kubrusly M, Mannstadt M, Hruby M, Tan MMTT, Silve C, Lacour B, Abou-Samra AB, Segre GV, Drueke T (1994) The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45:605–611

    Article  CAS  PubMed  Google Scholar 

  • Van den Branden C, Gabriels M, Vamecq J, Houte KV, Verbeelen D (1997) Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status: a comparative study of two β-blocking drugs, carvedilol and propranolol. Nephron 77:319–324

    Article  PubMed  Google Scholar 

  • Vaneerdeweg W, Buyssens N, De Winne T, Sebrechts M, Babloyan A, Arakelian S, De Broe ME (1992) A standard surgical technique to obtain a stable and reproducible chronic renal failure model in dogs. Eur Surg Res 24:273–282

    Article  CAS  PubMed  Google Scholar 

  • Vaziri ND, Oveisi F, Ding Y (1998) Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 53:1748–1754

    Article  CAS  PubMed  Google Scholar 

  • Wolf SC, Br B, Gaschler F, Brehm S, Klaussner M, Smykowski J, Amann K, Osswald H, Erley CM, Risler T (1999) Protective effects of endothelin antagonists in chronic renal failure. Nephrol Dial Transplant 14(Suppl 4):29–30

    Article  PubMed  Google Scholar 

  • Wong NLM, Wong EEC (1991) Increased release of atrial natriuretic peptide by the atria of rats with experimental renal failure. Nephron 57:89–93

    Article  CAS  PubMed  Google Scholar 

  • Wong NLM, Wong EEC (1992) Effect of dietary sodium on atrial natriuretic factor released in rats with chronic renal failure. Nephron 61:464–469

    Article  CAS  PubMed  Google Scholar 

  • Yi H, Fukagawa M, Yamamoto H, Kumagai M, Watanabe T, Kurokawa K (1995) Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats. Possible direct role of phosphorus. Nephron 70:242–248

    Article  CAS  PubMed  Google Scholar 

  • Zhou XJ, Pandian D, Wang QX, Vaziri ND (1997) Erythropoietin-induced hypertension is not mediated by alterations of plasma endothelin, vasopressin, or atrial natriuretic peptide levels. J Am Soc Nephrol 8:901–905

    CAS  PubMed  Google Scholar 

Experimental Nephritis

  • Chen Y-M, Chien C-T, Hu-Tsai M-I, Wu K-D, Tsai C-C, Wu MS, Tsai T-J (1999) Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Int 56:932–943

    Google Scholar 

  • Heymann W, Hackel DB, Harwood S, Wilson SGF, Hunter JLP (1959) Production of nephrotic syndrome in rats by Freund’s adjuvant and rat kidney suspension. Proc Soc Exp Biol Med 100:660–664

    Google Scholar 

  • Masugi M, Sato Y (1934) Ãœber die allergische Gewebsreaktion der Niere.Zugleich ein experimenteller Beitrag zur Pathogenese der diffusen Glomerulonephritis und der Periarteriitis nodosa. Virchows Arch Pathol Anat Physiol Klin Med 293:615–664

    Google Scholar 

  • Nagao T, Nagamatsu T, Suzuki Y (1994) Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats. Eur J Pharmacol 259:233–242

    Google Scholar 

  • Nagao T, Nagamatsu T, Suzuki Y (1998) Effect of lipo-prostaglandin E1 on crescentic-type anti-glomerular basement membrane nephritis in rats. Eur J Pharmacol 348:37–44

    Google Scholar 

  • Theofilopoulos AN, Dixon FJ (1981) Etiopathogenesis of murine SLE. Immunol Rev 55:179–216

    Article  CAS  PubMed  Google Scholar 

  • Unanue ER, Dixon FJ (1967) Experimental glomerulonephritis: immunological events and pathogenic mechanisms. Adv Immunol 6:1–90

    Google Scholar 

Nephrotoxic Serum Nephritis

  • Chen Y-M, Chien C-T, Hu-Tsai M-I, Wu K-D, Tsai C-C, Wu MS, Tsai T-J (1999) Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Int 56:932–943

    Google Scholar 

  • Couser WG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein LM (1978) Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 62:1275–1287

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Eddington TS, Glassock RJ, Dixon FJ (1968) Autologous immune complex nephritis induced with renal tubular antigen.I Identification and isolation of the pathogenic antigen. J Exp Med 127:555–572

    Article  Google Scholar 

  • Hamada N, Nagase M (1996) In vivo effect of OPC15161, a superoxide scavenger, on anti-Thy1 nephritis. Eur J Pharmacol 317:123–128

    Article  CAS  PubMed  Google Scholar 

  • Hara M, Batsford SR, Mihatsch MJ, Bitter-Suermann D, Vogt A (1991) Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats.Terminal complement components are not the sole mediators of proteinuria. Lab Invest 65:168–179

    CAS  PubMed  Google Scholar 

  • Hayashi K, Nagematsu T, Honda S, Suzuki Y (1996) Butein (3,4,2′,4′-tetrahydroxychalcone) ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. Eur J Pharmacol 316:279–306

    Article  Google Scholar 

  • Heise G, Grabensee B, Schrör K, Heering P (1998) Different actions of the cyclooxygenase 2 selective inhibitor flosulide in rats with passive Heymann nephritis. Nephron 80:220–226

    Article  CAS  PubMed  Google Scholar 

  • Heymann W, Hackel DB, Harwood S, Wilson SGF, Hunter JLP (1959) Production of nephrotic syndrome in rats by Freund’s adjuvant and rat kidney suspension. Proc Soc Exp Biol Med 100:660–664

    Google Scholar 

  • Heymann W, Kmetec EP, Wilson SGF, Hunter JLP, Hackel DB, Okuda R, Cuppage F (1965) Experimental autoimmune renal disease in rats. Ann N Y Acad Sci 124:310–315

    Article  CAS  PubMed  Google Scholar 

  • Ito M, Yamada H, Okamoto K, Suzuki Y (1983) Crescentic type nephritis induced by anti-glomerular basement membrane (GBM) serum in rats. Jpn J Pharmacol 33:1145–1154

    Article  CAS  PubMed  Google Scholar 

  • Kawasaki K, Yaoita E, Yamamoto T, Kihara I (1992) Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int 41:1517–1527

    Article  CAS  PubMed  Google Scholar 

  • Kawasaki K, Yaoita E, Yamamoto T, Kihara I (1995) Therapeutic effect of combined treatment with monoclonal antibodies against intercellular adhesion molecule 1 and lymphocyte-function-associated antigen 1 in Masugi nephritis of Wistar–Kyoto rats. Nephron 71:101–102

    Article  CAS  PubMed  Google Scholar 

  • Krakower CA, Greenspon SA (1951) Localization of nephrotoxic antigen within the isolated renal glomeruli. Arch Pathol 51:629–639

    CAS  Google Scholar 

  • Kushiro M, Shikata K, Sugimoto H, Shikata Y, Miyatake N, Wada J, Miyasaka M, Makino H (1998) Therapeutic effects of prostacyclin analog on crescentic glomerulonephritis of rat. Kidney Int 53:1314–1320

    Article  CAS  PubMed  Google Scholar 

  • Liebler S, Ãœberschär B, Kübert H, Brems S, Schnitger A, Tsukada M, Zouboulis CC, Ritz E, Wagner J (2004) The renal retinoid system: time dependent activation in experimental glomerulonephritis. Am J Physiol Renal Physiol 286:F458–F465

    Article  CAS  PubMed  Google Scholar 

  • Masugi M, Sato T (1934b) Virchows Arch Pathol Anat Physiol Klin Med 293:615

    Article  Google Scholar 

  • Nagamatsu T, Hayashi K, Oka T, Suzuki Y (1999) Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis. Eur J Pharmacol 374:93–101

    Article  CAS  PubMed  Google Scholar 

  • Nagao T, Nagamatsu T, Suzuki Y (1994) Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats. Eur J Pharmacol 259:233–242

    Google Scholar 

  • Nagao T, Nagamatsu T, Suzuki Y (1996) Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on passive Heymann nephritis in rats. Eur J Pharmacol 316:73–80

    Article  CAS  PubMed  Google Scholar 

  • Nagao T, Nagamatsu T, Suzuki Y (1998) Effect of lipo-prostaglandin E1 on crescentic-type anti-glomerular basement membrane nephritis in rats. Eur J Pharmacol 348:37–44

    Google Scholar 

  • Okubo Y, Tsukada Y, Maezawa A, Ono K, Yano S, Naruse T (1990) FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann’s nephritis and in the autologous phase of Masugi nephritis. Clin Exp Immunol 82:450–455

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Okuda S, Languino LR, Ruoslathi E, Border WA (1990) Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis.Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453–462

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rennke HG, Klein PS, Sandstrom DJ, Mendrick DL (1994) Cell-mediated immune injury in the kidney: acute nephritis induced by azobenzenearsonate. Kidney Int 45:1044–1056

    Article  CAS  PubMed  Google Scholar 

  • Sanaka T, Nakano Y, Nishimura H, Shinobe M, Higuchi C, Omata M, Nihei H, Sugino N (1997) Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis. Nephron 76:315–322

    Article  CAS  PubMed  Google Scholar 

  • Suzuki S, Gejyo F, Kuroda T, Kazama JJ, Imai N, Kimura H, Arakawa M (1998) Effect of a new elastase inhibitor, ONO-5046, on nephrotoxic serum nephritis in rats. Kidney Int 53:1208–1291

    Article  Google Scholar 

  • Tamatani T, Miyasaka M (1990) Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1 and evidence for differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int Immunol 2:165–171

    Article  CAS  PubMed  Google Scholar 

  • Thaiss F, Schoeppe W, Willaredt-Stoll JG, Batsford S, Mihatsch MJ (1989) Cyclosporin A prevents proteinuria in an active model of membranous nephropathy in rats. Lab Invest 61:661–669

    CAS  PubMed  Google Scholar 

  • Unanue ER, Dixon FJ (1967) Experimental glomerulonephritis: immunological events and pathogenic mechanisms. Adv Immunol 6:1–90

    Google Scholar 

Experimental Nephrosis

  • Abdel-Gayoum AA, El Jenjan KB, Ghwarsha KA (1999) Hyperlipidaemia in cisplatin-induced nephrotic rats. Hum Exp Toxicol 18:454–459

    Article  CAS  PubMed  Google Scholar 

  • Asami T, Toyabe S, Uchiyama M (1999) Effects of glutathione on aminonucleoside nephrosis in rats. Acta Med Biol 47:9–14

    CAS  Google Scholar 

  • Binder CJ, Weiher H, Exner M, Kerjaschki D (1999) Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria.A model of steroid-resistant nephrosis sensitive to radical scavenger therapy. Am J Pathol 154:1075–1967

    Article  Google Scholar 

  • Chagnac A, Korzets A, Ben Bassat M, Zevin D, Hirsh J, Meckler J, Levi J (1994) Uninephrectomy aggravates tubulointerstitial injury in rats with adriamycin nephrosis. Nephron 66:176–180

    Article  CAS  PubMed  Google Scholar 

  • De Boer E, Navis G, Wapstra FH, De Jong PE, De Zeeuw D (1999) Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable. Kidney Int 56(Suppl 71):S42–S46

    Article  Google Scholar 

  • Ebihara I, Nakamura T, Tomino Y, Koide H (1997) Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Nephrol Dial Transplant 12:1001–1006

    Article  CAS  PubMed  Google Scholar 

  • Guoji Y, Orita M, Tashiro K, Abe H (1994) Effects of glycyrrhetinic acid on aminonucleoside nephrosis in rats. Naunyn-Schmiedeberg’s Arch Pharmacol 349:318–323

    Article  CAS  Google Scholar 

  • Kimura M, Takahashi H, Ohtake T, Sato T, Hishida A, Nishimura M, Honda H (1993) Interstrain differences in murine daunomycin-induced nephrosis. Nephron 63:193–198

    CAS  PubMed  Google Scholar 

  • Klar S, Morrissey JJ (1997) Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int 52(Suppl 63):S-111–S-114

    Google Scholar 

  • Mackenzie HS, Ots M, Ziai F, Lee K-W, Kato S, Brenner BM (1997) Angiotensin receptor agonists in experimental models of chronic renal failure. Kidney Int 52(Suppl 63):140–143

    Google Scholar 

  • Magil A (1996) Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant. J Am Soc Nephrol 7:2340–2347

    CAS  PubMed  Google Scholar 

  • Milner LS, Wei SH, Houser MT (1991) Amelioration of glomerular injury in doxorubicin hydrochloride nephrosis by dimethylthiourea. J Lab Clin Med 118:427–434

    CAS  PubMed  Google Scholar 

  • Milner LS, Wei S, Kazakoff P, Watkins L, Houser MT (1994) Synergistic effect of fish oil diet and dimethylurea in acute adriamycin nephrosis. Am J Med Sci 308:266–270

    Article  CAS  PubMed  Google Scholar 

  • Mizuno S, Mizuno-Horikawa Y, Yue B-F, Okamoto M, Kurosawa T (1999) Nephrotic mice (ICGN strain): a model of diffuse mesangial sclerosis in infantile nephrotic syndrome. Am J Nephrol 19:73–82

    Article  CAS  PubMed  Google Scholar 

  • Mutti A, Coccini T, Alinovi R, Toubeau G, Broeckaert F, Bergamaschi E, Mozoni P, Nonclercq D, Bernard A, Manzo L (1999) Exposure to hydrocarbons and renal disease: an experimental animal model. Ren Fail 21:369–385

    Article  CAS  PubMed  Google Scholar 

  • Nosaka K, Takahashi T, Nishi T, Imaki H, Suzuki T, Suzuki K, Kurokawa K, Endou H (1997) An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity. Free Radic Biol Med 22:597–605

    Article  CAS  PubMed  Google Scholar 

  • Park Y-S, Guijarro C, Kim Y, Massy CA, Kasiske BL, Keane WF, O’Donnell MP (1998) Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Am J Kidney Dis 31:190–194

    Article  CAS  PubMed  Google Scholar 

  • Pedraza-Chaverri J, Granados-Silvestre MA, Medina-Campos ON, Hernández-Pando R (1999) Effect of the in vivo catalase inhibition on aminonucleoside nephrosis. Free Radic Biol Med 27:245–253

    Article  CAS  PubMed  Google Scholar 

  • Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D (1996) Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Clin Sci 90:339–340

    Google Scholar 

  • Yayama K, Kawao M, Tujii H, Itoh N, Okamoto H (1993) Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis. Eur J Pharmacol 236:337–338

    Article  CAS  PubMed  Google Scholar 

  • Yoneda H, Toriumi W, Ohmachi Y, Okumura F, Fujimura H, Nishiyama S (1998) Involvement of angiotensin II in development of spontaneous nephrosis in Dahl salt-sensitive rats. Eur J Pharmacol 362:213–219

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susan Emeigh Hart .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Hart, S.E. (2015). Impaired Renal Function. In: Hock, F. (eds) Drug Discovery and Evaluation: Pharmacological Assays. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27728-3_19-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27728-3_19-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27728-3

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics